According to this study, the positive impacts of ATD on the progress of hepatoblastoma cells were ascribed to its capacity to inhibit two signaling pathways activated by TGF‐β1: the P38MARK pathway and the Smad 2/3 pathway. The gene discussed is TGFB1; the disease is Jeune syndrome.